Literature DB >> 3011670

Bee venom melittin blocks neutrophil O2- production.

S D Somerfield, J L Stach, C Mraz, F Gervais, E Skamene.   

Abstract

Bee venom (BV) is used in folk medicine to treat arthritis. It has antiinflammatory effects in animal models of rheumatic disease. We have studied the effects of BV on human neutrophil production of superoxide (O2-) and hydrogen peroxide, finding potent, nontoxic, dose-dependent production inhibition. Melittin, the major fraction of BV (50-70%) shows high-affinity calmodulin binding (Kd 3 nM). Drugs which bind calmodulin, such as trifluoperazine, inhibit O2- production by human neutrophils. For these reasons we have investigated the effect of melittin and other BV peptides on O2- production by human peripheral blood leukocytes. We show that melittin inhibited O2- production both pre- and poststimulation in contrast to other BV fractions which were without effect. Oxygen radicals and their derivatives from inflammatory cells are implicated in the tissue damage occurring during inflammation. The inhibition is due to a direct effect on cells, and not indicator medium, dismutation, toxic or scavenging effects. We propose that melittin may serve as a prototype small (mol wt 1280), cationic, amphipathic, calmodulin-binding, membrane-active, superoxide-production-inhibiting peptide, providing a model for peptides which could have a role in in vivo regulation of radical production.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3011670     DOI: 10.1007/bf00915999

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  28 in total

1.  Superoxide generation by digitonin-stimulated guinea pig granulocytes. A basis for a continuous assay for monitoring superoxide production and for the study of the activation of the generating system.

Authors:  H J Cohen; M E Chovaniec
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

2.  Influence of bee venom in the adjuvant-induced arthritic rat model.

Authors:  O J Lorenzetti; B Fortenberry; E Busby
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1972-09

3.  The roles of extracellular and intracellular calcium in lysosomal enzyme release and superoxide anion generation by human neutrophils.

Authors:  J E Smolen; H M Korchak; G Weissmann
Journal:  Biochim Biophys Acta       Date:  1981-11-05

4.  Involvement of calmodulin in phagocytotic respiratory burst of leukocytes.

Authors:  K Takeshige; S Minakami
Journal:  Biochem Biophys Res Commun       Date:  1981-03-31       Impact factor: 3.575

5.  The effects of endogenous phospholipase A2 activation on beta adrenoceptor function in cardiac cells.

Authors:  A Bobik; J Campbell; P Snow; P J Little
Journal:  J Mol Cell Cardiol       Date:  1983-11       Impact factor: 5.000

6.  Free radical pathology.

Authors:  J D Butterfield; C P McGraw
Journal:  Stroke       Date:  1978 Sep-Oct       Impact factor: 7.914

7.  Calmodulin-dependent stimulation of the NADPH oxidase of human neutrophils.

Authors:  H P Jones; G Ghai; W F Petrone; J M McCord
Journal:  Biochim Biophys Acta       Date:  1982-01-12

8.  Optimal conditions for simultaneous purification of mononuclear and polymorphonuclear leucocytes from human blood by the Hypaque-Ficoll method.

Authors:  A Ferrante; Y H Thong
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

9.  Effects of trifluoperazine on human neutrophil function.

Authors:  R J Smith; B J Bowman; S S Iden
Journal:  Immunology       Date:  1981-12       Impact factor: 7.397

10.  Anti-arthritic effect of bee venom.

Authors:  Y H Chang; M L Bliven
Journal:  Agents Actions       Date:  1979-06
View more
  2 in total

1.  Effect of Staphylococcus aureus delta-toxin on human granulocyte functions and platelet-activating-factor metabolism.

Authors:  S Kasimir; W Schönfeld; J E Alouf; W König
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

2.  Melittin inhibits the invasion of MCF-7 cells by downregulating CD147 and MMP-9 expression.

Authors:  Jianjun Wang; Fengyu Li; Jiang Tan; Xuewei Peng; Lili Sun; Ping Wang; Shengnan Jia; Qingmiao Yu; Hongliang Huo; Hongyan Zhao
Journal:  Oncol Lett       Date:  2016-12-20       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.